Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2015	Aug. 01, 2014
Operating Activities:
Net income	$ 107,192	$ 194,101
Adjustments to continuing operations:
Depreciation and amortization	102,914	98,725
Changes in deferred income taxes	7,463	(5,864)
Contributions to defined benefit employee pension plans	(12,106)	(5,760)
Defined benefit employee pension plan expense	15,786	13,575
Share-based compensation expense	23,846	11,204
Changes in long-term receivables	11,335	(2,650)
Other adjustments to continuing operations, net	697	(5,556)
Changes in working capital items attributed to continuing operations:
Accounts receivable, net	198,081	214,448
Inventories	(120,377)	(84,439)
Other current assets	(17,265)	12,324
Trade accounts payable	(60,936)	(29,442)
Employee compensation and benefits	(55,106)	(15,291)
Advance payments and progress billings	35,462	(3,352)
Accrued warranties	(9,800)	(21,579)
Other accrued liabilities	(58,472)	(72,123)
Net cash provided by operating activities of continuing operations	168,714	298,321
Net cash used by operating activities of discontinued operations	0	(103)
Net cash provided by operating activities	168,714	298,218
Investing Activities:
Acquisition of businesses, net of cash acquired	(114,353)	(47,058)
Property, plant and equipment acquired	(57,821)	(69,068)
Proceeds from sale of property, plant and equipment	4,071	8,882
Other investing activities, net	625	(89)
Net cash used by investing activities	(167,478)	(107,333)
Financing Activities:
Common stock issued	2,853	10,189
Dividends paid	(58,456)	(55,334)
Repayments of term loan	0	(37,500)
Repayments of short term debt	(11,545)
Treasury stock purchased	(50,000)	(194,336)
Other financing activities, net	261	(10,319)
Net cash used by financing activities	(116,887)	(287,300)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	13,640	1,252
Decrease in Cash and Cash Equivalents	(129,291)	(97,667)
Cash and Cash Equivalents at Beginning of Period	270,191	405,709
Cash and Cash Equivalents at End of Period	$ 140,900	$ 308,042